Quest Pharmatech Inc V.QPT

Zero news

[PosNeg1]

Absolutely nada shared with investors, financials way overdue last filed Dec 23 2021, one PR saying they borrowed 1M against future possible payment.

[G1945V]

If Quest Pharmatech Inc's ("QPT") survival depends on them borrowing a million dollars to stay alive, from OncoQuest Inc, rather than generating income on their own this does not bode well for QPT shareholders. They will simply keep on borrowing against future possible payments from OncoQuest Inc. Just to note that OncoQuest Inc had received US$8,387,503 in cash from OQP, as stated

[PosNeg1]

A phase III cancer immunotherapy program in clinical trials currently and a SP that has been 0.10 or so for several years. Hello? Fate in CEO's hands, I hope not.

[G1945V]

What other choice do we have? G1945V

[ARIMA11]

Financial are out and its definitely not pretty! Basic income (loss) / share at Jan 31 22 (-0.50) vs. Jan 31 2021 (+1.13) is interesting and notable. Auditor Statements Emphasis of Matter - Material Uncertainty Relating to Going Concern: We draw your attention to Note 1 in the consolidated financial statements, which indicates that the Company reported a net loss $85,038,575 during the year

[G1945V]

"Company reported a net loss of $85,038,575 during the year ended January 31, 2022" This is a superficial loss due to the adjustments noted in Note 20 of the financials. ($57,754,078) & ($26,748,980) Actual net loss before the under noted issues (note 20)  ($790,573.00) Why "OncoQuest" did what they did without guarantees was not wise, to say the least! jmo G1945V